Ropes & Gray has advised Chiesi Farmaceutici S.p.A. Kirkland & Ellis and Fenwick & West have advised KalVista Pharmaceuticals, Inc. Chiesi Farmaceutici S.p.A., an international biopharmaceutical...
Chiesi to Acquire KalVista Pharmaceuticals in $1.9 Billion Deal
Angelini Pharma Acquires Catalyst Pharmaceuticals in $4.1 Billion Deal
Hogan Lovells, Gatti Pavesi Bianchi Ludovici, and Maisto e Associati have advised Angelini Pharma. Linklaters has advised BNP Paribas. Legance has advised Blackstone. Kirkland & Ellis...
BioMarin to Acquire Amicus Therapeutics for $4.8 Billion
Jones Day has advised BioMarin Pharmaceutical Inc. in the acquisition of Amicus Therapeutics. Kirkland & Ellis has advised Amicus Therapeutics. BioMarin Pharmaceutical Inc. (Nasdaq: BMRN) has...
Novo Nordisk to Acquire Akero Therapeutics for Up to $5.2 Billion
Ropes & Gray has advised Novo Nordisk, and Kirkland & Ellis has advised Akero Therapeutics. Novo Nordisk has entered into a definitive agreement to acquire Akero...
Emerson’s $7.2 Billion Acquisition of Remaining Outstanding Shares of AspenTech
Davis Polk & Wardwell is serving as legal advisor to Emerson, while Skadden, Arps, Slate, Meagher & Flom is serving as legal counsel to the AspenTech...
Johnson & Johnson’s Acquisition of Ambrx Biopharma
Cravath, Swaine & Moore is serving as legal counsel to Johnson & Johnson, while Skadden is serving as legal counsel to Ambrx Biopharma on the transaction....
Eli Lilly’s $1.4 Billion Acquisition of POINT Biopharma
Kirkland & Ellis LLP is acting as legal counsel to Lilly, while Skadden, Arps, Slate, Meagher & Flom LLP is acting as legal counsel to POINT...
Wendel Group and Colibri Group’s $1 Billion Acquisition of Financial Services Segment From Adtalem Global Education
Finn Dixon & Herling acted as legal counsel to Colibri and Gridiron, while Kirkland & Ellis, as Wendel’s legal advisor. Skadden, Arps, Slate, Meagher & Flom...
AspenTech’s Merger With Emerson Electric Co.’s
Simpson Thacher advised JPMorgan as financial advisor on the deal, while Davis Polk advised Emerson. Skadden, Arps, Slate, Meagher & Flom advised AspenTech. Aspen Technology, Inc....
Xeris Pharmaceuticals’ Acquisition of Strongbridge Biopharma
Skadden, Arps, Slate, Meagher & Flom, LLP and Arthur Cox LLP advised Strongbridge, while Goodwin Procter LLP and A&L Goodbody LLP advised Xeris on the deal....
Xeris Pharmaceuticals’ Acquisition of Strongbridge Biopharma
Skadden, Arps, Slate, Meagher & Flom, LLP and Arthur Cox LLP advised Strongbridge, while Goodwin Procter LLP and A&L Goodbody LLP advised Xeris on the deal....
Alcon’s Acquisition of U.S. Commercialization Rights to Ophthalmic Eye Drop Simbrinza
Skadden, Arps, Slate, Meagher & Flom LLP advised Alcon on the deal. Alcon, the global leader in eye care dedicated to helping people see brilliantly, has...